Page last updated: 2024-11-05

trazodone and Amphetamine-Related Disorders

trazodone has been researched along with Amphetamine-Related Disorders in 3 studies

Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.

Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Petrie, MS1
Lynch, KL1
Wu, AH1
Steinhardt, AA1
Horowitz, GL1
Ganetsky, M1
Milone, MC1

Other Studies

3 other studies available for trazodone and Amphetamine-Related Disorders

ArticleYear
Prescription compliance or illicit designer drug abuse?
    Clinical chemistry, 2012, Volume: 58, Issue:12

    Topics: Amphetamine-Related Disorders; Antidepressive Agents; Bupropion; Cross Reactions; Designer Drugs; Fa

2012
Commentary.
    Clinical chemistry, 2012, Volume: 58, Issue:12

    Topics: Amphetamine-Related Disorders; Antidepressive Agents; Designer Drugs; Female; Humans; Medication Adh

2012
Commentary.
    Clinical chemistry, 2012, Volume: 58, Issue:12

    Topics: Amphetamine-Related Disorders; Antidepressive Agents; Designer Drugs; Female; Humans; Medication Adh

2012